Safety of sodium-glucose co-transporter-2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess the risk of amputation associated with sodium-glucose co-transporter-2 inhibitors (SGLT2is) among patients with type 2 diabetes, across categories of baseline cardiovascular disease (CVD) and diuretic use (DU).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabetes Obes Metab

Title: Diabetes, obesity & metabolism

Publisher: Wiley

ISSN (Electronic): 1463-1326

ISSN (Print): 1462-8902

Publication date (Electronic): Nov 2023

Volume: 25

Issue: 11

Affiliations

[1 ] School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.

[2 ] Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.

[3 ] Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Republic of Korea.

[4 ] Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

[5 ] Division of Endocrinology and Metabolism, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

[6 ] Department of Internal Medicine Seoul National University College of Medicine, Seoul, South Korea.

[7 ] Department of Translational Medicine, Seoul National University College of Medicine, Seoul, South Korea.

[8 ] Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

[9 ] Institute on Aging, Seoul National University, Seoul, South Korea.

[10 ] Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.

[11 ] Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, UK.

[12 ] Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong.

[13 ] Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.

Article

DOI: 10.1111/dom.15221

PubMed ID: 37503763

SO-VID: de66f710-03f4-4368-88d5-2f8ce8b914d1

History

Keywords: type 2 diabetes,cardiovascular disease,diuretics,amputation,SGLT2 inhibitors

Data availability:

Keywords: type 2 diabetes, cardiovascular disease, diuretics, amputation, SGLT2 inhibitors

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 2

See all cited by